CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA
Publication
, Conference
Shoaf, M; Chow, F; Xiu, J; Glantz, M; Aulakh, S; Ashley, D; Lipp, ES; Lopez, G; Sumrall, A; Walker, P; Spetzler, D; Nicolaides, T; Peters, KB
Published in: Neuro Oncology
2022
Duke Scholars
Published In
Neuro Oncology
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
154 / 155
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shoaf, M., Chow, F., Xiu, J., Glantz, M., Aulakh, S., Ashley, D., … Peters, K. B. (2022). CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA. In Neuro Oncology (Vol. 24, pp. 154–155).
Shoaf, Madison, Frances Chow, Joanne Xiu, Michael Glantz, Sonikpreet Aulakh, David Ashley, Eric S. Lipp, et al. “CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA.” In Neuro Oncology, 24:154–55, 2022.
Shoaf M, Chow F, Xiu J, Glantz M, Aulakh S, Ashley D, et al. CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA. In: Neuro Oncology. 2022. p. 154–5.
Shoaf, Madison, et al. “CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA.” Neuro Oncology, vol. 24, 2022, pp. 154–55.
Shoaf M, Chow F, Xiu J, Glantz M, Aulakh S, Ashley D, Lipp ES, Lopez G, Sumrall A, Walker P, Spetzler D, Nicolaides T, Peters KB. CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA. Neuro Oncology. 2022. p. 154–155.
Published In
Neuro Oncology
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
154 / 155
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences